Literature DB >> 4372960

Clinical application of cytochrome a(plus a3) assay of mitochondria from liver specimens: an aid in determining metabolic tolerance of liver remnant for hepatic resection.

K Ozawa, Y Yamaoka, O Kitamura, H Nambu, Y Kamiyama.   

Abstract

Measurement of cytochrome a(+a(3)) contents in liver mitochondria was made on 52 biopsy specimens of patients with liver tumor. Patients having higher cytochrome a(+a(3)) contents in mitochondria from remaining liver than those of normal human liver mitochondria could survive well major liver resections whether or not associated with liver cirrhosis. However, patients with cytochrome a(+a(3)) contents less than 0.5 x 10(-10) moles per mg protein showed a high rate of postoperative complication (80%) and death (40%) in spite of minor operation. In routinely used liver function tests such as serum albumin, A/G ratio, SGOT, total bilirubin, prothrombin time, BSP and TTT, there were no significant differences between patients with cytochrome a(+a(3)) contents more than 0.5 x 10(-10) moles per mg protein and those less than 0.5. The results indicate that routine laboratory studies do not have much diagnostic value in estimation of a marked decrease of mitochondrial cytochrome a(+a(3)) contents. It is suggested that the measurements of cytochrome a(+a(3)) of the remnant liver should be done prior to a contemplated major resection.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4372960      PMCID: PMC1343812          DOI: 10.1097/00000658-197412000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  12 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Hepatic cellular responses to liver cancer: abnormalities in metabolism of mitochondria isolated from human liver involved with carcinoma.

Authors:  K Ozawa; O Kitamura; Y Yamaoka; T Kamano; T Mizukami
Journal:  Ann Surg       Date:  1974-01       Impact factor: 12.969

3.  Phosphorylative capacity of liver mitochondria with an elevated ratio of cytochrome c+c1 to cytochrome a(+a3).

Authors:  K Ozawa; O Kitamura; Y Yamaoka; H Nanbu; I Honjo
Journal:  J Lab Clin Med       Date:  1974-01

4.  Role of portal blood on the enhancement of liver mitochondrial metabolism.

Authors:  K Ozawa; O Kitamura; Y Yamaoka; T Mizukami; T Kamano
Journal:  Am J Surg       Date:  1972-07       Impact factor: 2.565

5.  Effect of ligation of portal vein on liver mitochondrial metabolism.

Authors:  K Ozawa; H Takasan; O Kitamura; T Mizukami; T Kamano
Journal:  J Biochem       Date:  1971-11       Impact factor: 3.387

6.  Biochemical adaptations in muscle. II. Response of mitochondrial adenosine triphosphatase, creatine phosphokinase, and adenylate kinase activities in skeletal muscle to exercise.

Authors:  L B Oscai; J O Holloszy
Journal:  J Biol Chem       Date:  1971-11-25       Impact factor: 5.157

7.  Insulin as the primary factor governing changes in mitochondrial metabolism leading to liver regeneration and atrophy.

Authors:  K Ozawa; Y Yamaoka; H Nanbu; I Honjo
Journal:  Am J Surg       Date:  1974-06       Impact factor: 2.565

8.  Quantitative analysis of respiratory enzymes of mitochondria isolated from liver tissue of patients.

Authors:  K Ozawa; O Kitamura; Y Yamaoka; T Mizukami; T Kamano
Journal:  J Lab Clin Med       Date:  1973-03

9.  Human liver mitochondria.

Authors:  K Ozawa; O Kitamura; T Mizukami; Y Yamaoka; T Kamano
Journal:  Clin Chim Acta       Date:  1972-05       Impact factor: 3.786

10.  Physiologic considerations in major hepatic resections.

Authors:  H H Stone; W D Long; R B Smith; C D Haynes
Journal:  Am J Surg       Date:  1969-01       Impact factor: 2.565

View more
  7 in total

1.  The significance of serum mitochondrial aspartate aminotransferase activity in obstructive jaundice: experimental and clinical studies.

Authors:  E Sada; S Tashiro; Y Morino
Journal:  Jpn J Surg       Date:  1990-07

2.  Response of hepatic mitochondrial redox state to oral glucose load. Redox tolerance test as a new predictor of surgical risk in hepatectomy.

Authors:  K Mori; K Ozawa; Y Yamamoto; A Maki; Y Shimahara; N Kobayashi; Y Yamaoka; K Kumada
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

3.  Regional therapy in the management of intrahepatic recurrence after surgery for hepatoma.

Authors:  Y Sasaki; S Imaoka; M Fujita; Y Miyoshi; H Ohigashi; O Ishikawa; H Furukawa; H Koyama; T Iwanaga; H Kasugai
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

4.  Preoperative Biliary Drainage Is Associated with Increased Complications After Liver Resection for Proximal Cholangiocarcinoma.

Authors:  Rajesh Ramanathan; Jeffrey Borrebach; Samer Tohme; Allan Tsung
Journal:  J Gastrointest Surg       Date:  2018-07-06       Impact factor: 3.452

5.  Remnant liver function during surgery for extensive hepatic resection.

Authors:  N Nagasue; K Inokuchi; A Iwaki; H Yukaya; R Kanashima; M Saku; M Kobayashi
Journal:  Jpn J Surg       Date:  1979-06

6.  A metabolic disorder similar to Zellweger syndrome with hepatic acatalasia and absence of peroxisomes, altered content and redox state of cytochromes, and infantile cirrhosis with hemosiderosis.

Authors:  H T Versmold; H J Bremer; V Herzog; G Siegel; D B Bassewitz; U Irle; H Voss; I Lombeck; B Brauser
Journal:  Eur J Pediatr       Date:  1977-03-18       Impact factor: 3.183

7.  Sonographic characteristics of recurrent hepatocellular carcinoma.

Authors:  T Shibata; H Sakahara; S Kawakami; J Konishi
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.